Patent Specification Concerns Make IPRs Tricky For Drug Cos.
Attorneys on both sides of drug patent challenges at the Patent Trial and Appeal Board have to be extremely cautious to draft an obviousness argument in a way that doesn't undermine...To view the full article, register now.
Already a subscriber? Click here to view full article